BridgeBio Pharma, Inc. (BBIO)
NASDAQ·Healthcare·Biotechnology
$66.12
-4.49%
Mkt Cap $13.05B
Analyst Ratings
Buy
21
Hold
1
Sell
0
Price Target (52 analysts)
$110.09
Range $97.00 – $130.00
Implied Upside
+66.5%
Consensus $110.09 vs current $66.12
NASDAQ·Healthcare·Biotechnology
$66.12
-4.49%
Mkt Cap $13.05B
Buy
21
Hold
1
Sell
0
Price Target (52 analysts)
$110.09
Range $97.00 – $130.00
+66.5%
Consensus $110.09 vs current $66.12